Airline Stocks – Feb 11, 2021 – Nicholas Investment Partners, LP Buys Arena Pharmaceuticals Inc, TG Therapeutics Inc, Avantor Inc, Sells Immunomedics Inc, MyoKardia Inc, Global Blood Therapeutics Inc

Del Mar, CA, based Investment company Nicholas Investment Partners, LP (Current Portfolio) buys Arena Pharmaceuticals Inc, TG Therapeutics Inc, Avantor Inc, Berkeley Lights Inc, Zai Lab, sells Immunomedics Inc, MyoKardia Inc, Global Blood Therapeutics Inc, Penumbra Inc, Esperion Therapeutics Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Nicholas Investment Partners, LP. As of 2020Q4, Nicholas Investment Partners, LP owns 146 stocks with a total value of $1.2 billion. These are the details of the buys and sells.

• New Purchases: ARNA, AVTR, ZLAB, CVX, TXG, BAC, ARES, C, GS, GTLS, ZION, WAL, MASS, SHOO, SEER, BX, VICI, DOW, ABBV, FITB, RDS.B, BA, REAL, PRU, MRTN, PNR, ULTA, DECK,
• Added Positions: TGTX, BLI, BBIO, JBLU, TDOC, WSC, COUP, AMZN, TSM, ESTC, AFIB, STKL, OSH, TRIL, KTB, DCPH, STAY, GH, VC, BHVN, AXSM, HZNP, CLAR, DIS, JACK, DKNG, AYX, SDGR, EVBG, MA, PODD, SRPT, BURL, FIVN, IWM, KRYS, CDLX, MDLA, ELY, PTVE, TEAM, IAC, CSGP, RNG, ADBE, CZR, SPLK, ODFL, ANSS, EAT, KLAC, AMD, ADI, CDNS, JBHT, TWLO, MSFT, LUV, FRC, SQ, INTU, NVDA,
• Reduced Positions: NVCR, TWST, TREX, FRPT, FIVE, AMRC, ITCI, PLMR, LSCC, BMRN, UTZ, IIPR, GOOG, KRNT, CRNC, VITL, BBY, TFII, LULU, CMG,
• Sold Out: IMMU, MYOK, GBT, PEN, ESPR, SAGE, BACPL.PFD, LVGO, HPP, SWCH, SKYW, TXRH, LECO, FFWM, PRLB, DOC, HD, CVLG, MANT, LPLA, GPN, CABO, RMD, ALXN, IDXX, ZBH,

For the details of Nicholas Investment Partners, LP’s stock buys and sells,
go to https://www.gurufocus.com/guru/nicholas+investment+partners%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of Nicholas Investment Partners, LP

1. TG Therapeutics Inc (TGTX) – 628,172 shares, 2.82% of the total portfolio. Shares added by 173.77%
2. BridgeBio Pharma Inc (BBIO) – 411,771 shares, 2.53% of the total portfolio. Shares added by 40.54%
3. Teladoc Health Inc (TDOC) – 126,104 shares, 2.18% of the total portfolio. Shares added by 35.01%
4. Twist Bioscience Corp (TWST) – 178,875 shares, 2.18% of the total portfolio. Shares reduced by 33.63%
5. Repligen Corp (RGEN) – 130,491 shares, 2.16% of the total portfolio. Shares added by 0.22%

New Purchase: Arena Pharmaceuticals Inc (ARNA)

Nicholas Investment Partners, LP initiated holding in Arena Pharmaceuticals Inc. The purchase prices were between $63.85 and $87.71, with an estimated average price of $74.94. The stock is now traded at around $83.020000. The impact to a portfolio due to this purchase was 1.83%. The holding were 276,633 shares as of 2020-12-31.

New Purchase: Avantor Inc (AVTR)

Nicholas Investment Partners, LP initiated holding in Avantor Inc. The purchase prices were between $22.9 and $28.15, with an estimated average price of $25.82. The stock is now traded at around $30.580000. The impact to a portfolio due to this purchase was 1.41%. The holding were 579,037 shares as of 2020-12-31.

New Purchase: Zai Lab Ltd (ZLAB)

Nicholas Investment Partners, LP initiated holding in Zai Lab Ltd. The purchase prices were between $81.94 and $135.34, with an estimated average price of $102.02. The stock is now traded at around $180.010100. The impact to a portfolio due to this purchase was 1.04%. The holding were 88,871 shares as of 2020-12-31.

New Purchase: Chevron Corp (CVX)

Nicholas Investment Partners, LP initiated holding in Chevron Corp. The purchase prices were between $66.88 and $95.62, with an estimated average price of $81.13. The stock is now traded at around $91.900000. The impact to a portfolio due to this purchase was 0.88%. The holding were 120,938 shares as of 2020-12-31.

New Purchase: 10x Genomics Inc (TXG)

Nicholas Investment Partners, LP initiated holding in 10x Genomics Inc. The purchase prices were between $128.12 and $163.7, with an estimated average price of $145.41. The stock is now traded at around $188.460000. The impact to a portfolio due to this purchase was 0.87%. The holding were 70,915 shares as of 2020-12-31.

New Purchase: Bank of America Corp (BAC)

Nicholas Investment Partners, LP initiated holding in Bank of America Corp. The purchase prices were between $23.47 and $30.31, with an estimated average price of $26.85. The stock is now traded at around $32.980000. The impact to a portfolio due to this purchase was 0.82%. The holding were 314,428 shares as of 2020-12-31.

Added: TG Therapeutics Inc (TGTX)

Nicholas Investment Partners, LP added to a holding in TG Therapeutics Inc by 173.77%. The purchase prices were between $25.27 and $54.9, with an estimated average price of $33.89. The stock is now traded at around $50.455000. The impact to a portfolio due to this purchase was 1.79%. The holding were 628,172 shares as of 2020-12-31.

Added: Berkeley Lights Inc (BLI)

Nicholas Investment Partners, LP added to a holding in Berkeley Lights Inc by 320.31%. The purchase prices were between $70.38 and $106, with an estimated average price of $84.23. The stock is now traded at around $78.050000. The impact to a portfolio due to this purchase was 1.04%. The holding were 177,724 shares as of 2020-12-31.

Added: BridgeBio Pharma Inc (BBIO)

Nicholas Investment Partners, LP added to a holding in BridgeBio Pharma Inc by 40.54%. The purchase prices were between $38.38 and $71.11, with an estimated average price of $48.38. The stock is now traded at around $69.615000. The impact to a portfolio due to this purchase was 0.73%. The holding were 411,771 shares as of 2020-12-31.

Added: JetBlue Airways Corp (JBLU)

Nicholas Investment Partners, LP added to a holding in JetBlue Airways Corp by 545.14%. The purchase prices were between $11.11 and $15.89, with an estimated average price of $13.76. The stock is now traded at around $16.475000. The impact to a portfolio due to this purchase was 0.63%. The holding were 587,512 shares as of 2020-12-31.

Added: Teladoc Health Inc (TDOC)

Nicholas Investment Partners, LP added to a holding in Teladoc Health Inc by 35.01%. The purchase prices were between $172.44 and $231.8, with an estimated average price of $203.06. The stock is now traded at around $288.480000. The impact to a portfolio due to this purchase was 0.57%. The holding were 126,104 shares as of 2020-12-31.

Added: WillScot Mobile Mini Holdings Corp (WSC)

Nicholas Investment Partners, LP added to a holding in WillScot Mobile Mini Holdings Corp by 187.58%. The purchase prices were between $17.03 and $23.17, with an estimated average price of $20.22. The stock is now traded at around $27.070000. The impact to a portfolio due to this purchase was 0.55%. The holding were 423,478 shares as of 2020-12-31.

Sold Out: Immunomedics Inc (IMMU)

Nicholas Investment Partners, LP sold out a holding in Immunomedics Inc. The sale prices were between $85.08 and $87.86, with an estimated average price of $86.65.

Sold Out: MyoKardia Inc (MYOK)

Nicholas Investment Partners, LP sold out a holding in MyoKardia Inc. The sale prices were between $139.6 and $224.91, with an estimated average price of $220.55.

Sold Out: Global Blood Therapeutics Inc (GBT)

Nicholas Investment Partners, LP sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $37.65 and $63.77, with an estimated average price of $49.17.

Sold Out: Penumbra Inc (PEN)

Nicholas Investment Partners, LP sold out a holding in Penumbra Inc. The sale prices were between $174.98 and $272.83, with an estimated average price of $219.52.

Sold Out: Esperion Therapeutics Inc (ESPR)

Nicholas Investment Partners, LP sold out a holding in Esperion Therapeutics Inc. The sale prices were between $24.2 and $35.55, with an estimated average price of $29.86.

Sold Out: Sage Therapeutics Inc (SAGE)

Nicholas Investment Partners, LP sold out a holding in Sage Therapeutics Inc. The sale prices were between $58.41 and $89.06, with an estimated average price of $73.93.

Here is the complete portfolio of Nicholas Investment Partners, LP. Also check out:

1. Nicholas Investment Partners, LP’s Undervalued Stocks
2. Nicholas Investment Partners, LP’s Top Growth Companies, and
3. Nicholas Investment Partners, LP’s High Yield stocks
4. Stocks that Nicholas Investment Partners, LP keeps buying